Elevated miR-9 in Cerebrospinal Fluid Is Associated with Poor Functional Outcome After Subarachnoid Hemorrhage
- 4 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Translational Stroke Research
- Vol. 11 (6), 1243-1252
- https://doi.org/10.1007/s12975-020-00793-1
Abstract
This study evaluated microRNA (miRNA) changes in cerebrospinal fluid (CSF) and their association with the occurrence of delayed cerebral ischemia (DCI) and poor functional outcome after SAH. Forty-three selected miRNAs were measured in daily CSF samples from a discovery cohort of SAH patients admitted to Rigshospitalet, Copenhagen, Denmark, and compared with neurologically healthy patients. Findings were validated in CSF from a replication cohort of SAH patients admitted to Massachusetts General Hospital, Boston, Massachusetts. The CSF levels of miRNA over time were compared with the occurrence of DCI, and functional outcome after 3 months. miRNAs were quantified in 427 CSF samples from 63 SAH patients in the discovery cohort, in 104 CSF samples from 63 SAH patients in the replication cohort, and in 11 CSF samples from 11 neurologically healthy patients. The miRNA profile changed remarkably immediately after SAH. Elevated miR-9-3p was associated with a poor functional outcome in the discovery cohort (p < 0.0001) after correction for multiple testing (q < 0.01) and in the replication cohort (p < 0.01). Furthermore, elevated miR-9-5p was associated with a poor functional outcome in the discovery cohort (p < 0.01) after correction for multiple testing (q < 0.05). No miRNA was associated with DCI in both cohorts. miR-9-3p and miR-9-5p are elevated in the CSF following SAH and this elevation is associated with a poor functional outcome. These elevations have potential roles in the progression of cerebral injury and could add to early prognostication.Keywords
Funding Information
- Lundbeckfonden (R212-2015-1987)
- Lundbeckfonden (R211-2015-3844)
This publication has 33 references indexed in Scilit:
- The Impact of Hemolysis on Cell-Free microRNA BiomarkersFrontiers in Genetics, 2013
- MicroRNAs in body fluids—the mix of hormones and biomarkersNature Reviews Clinical Oncology, 2011
- Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational StudiesStroke, 2010
- A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiationNucleic Acids Research, 2010
- MicroRNAs as Effectors of Brain Function with Roles in Ischemia and Injury, Neuroprotection, and NeurodegenerationJournal of Cerebral Blood Flow & Metabolism, 2010
- A novel and universal method for microRNA RT-qPCR data normalizationGenome Biology, 2009
- The Bifunctional microRNA miR-9/miR-9* Regulates REST and CoREST and Is Downregulated in Huntington's DiseaseJournal of Neuroscience, 2008
- An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegansScience, 2001
- Identification of Novel Genes Coding for Small Expressed RNAsScience, 2001
- A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies.Journal of Neurology, Neurosurgery & Psychiatry, 1988